The macroepidemiology of influenza vaccination in 56 countries, 1997-2003
The macroepidemiology of influenza vaccination in 56 countries, 1997-2003
复制标题
DOI：
10.1016/j.vaccine.2005.06.010
复制
发表时间：
2005-10-25
期刊：
影响因子：
5.5
通讯作者：
Vidmar, S
中科院分区：
文献类型：
--
作者：
Fedson, DS;Kunze, M;Vidmar, S
世卫组织全球流感议程呼吁衡量国家流感疫苗接种计划的进展情况。作为回应，流感疫苗接种宏观流行病学（MIV）研究小组收集了56个国家的流感疫苗接种信息。1997-2003年期间，几乎所有国家的流感疫苗分发量都有大幅度增加。2003年，疫苗接种率最高的国家（每1 000人分发的剂量）是加拿大（344）、大韩民国（311）、美国（286）和日本（230）。大多数国家建议为老年人和有高风险疾病（包括免疫力低下）的人接种流感疫苗。通过国家或社会医疗保险向公众报销疫苗接种费用的国家较少。较高的疫苗接种水平与较高的经济发展水平并不密切相关，但在许多情况下，公众对疫苗接种的报销似乎与更多的疫苗使用有关。从1994年到2003年，全球流感疫苗的使用量增加了两倍多。2003年，MIV研究组的56个国家约占全球分发的2.92亿剂流感疫苗的95%，其中62%的疫苗是在北美、西欧、日本和澳大利亚的9个疫苗生产国分发的。然而，在许多非疫苗生产国，流感疫苗接种正在迅速增加，这一变化对大流行疫苗接种具有重要意义。(c)2005爱思唯尔有限公司保留所有权利。
The WHO Global Agenda on Influenza calls for measuring the progress of national influenza vaccination programs. In response, the Macroepidemiology of Influenza Vaccination (MIV) Study Group has gathered information on influenza vaccination in 56 countries. During the period 1997-2003, influenza vaccine distribution increased considerably in almost all countries. In 2003, the countries with the highest levels of vaccination (doses distributed/1000 population) were Canada (344), the Republic of Korea (311), the United States (286) and Japan (230). Most countries recommended influenza vaccination for elderly persons and those with high-risk medical conditions, including immunocompromise. Fewer countries provided public reimbursement for vaccination through national or social health insurance. Higher levels of vaccination were not closely related to higher levels of economic development, but in many instances public reimbursement for vaccination seemed to be associated with greater vaccine use. From 1994 to 2003, the global use of influenza vaccines increased more than two-fold. In 2003, the 56 MIV Study Group countries accounted for approximately 95% of the 292 million doses of influenza vaccine distributed worldwide, and 62% of these doses were distributed within nine vaccine-producing countries in North America, Western Europe, Japan and Australia. However, influenza vaccination was increasing rapidly in many non vaccine-producing countries, and this change has important implications for pandemic vaccination. (c) 2005 Elsevier Ltd. All rights reserved.